Back

Panel discussion and conclusion

18 May 2025 (15:36 - 15:45)
Organised by: Logo
Congress Presentation Part of: Redefining mineralocorticoid receptor antagonism in cardio-kidney-metabolic syndrome: from evidence to innovation Treatment HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

5 More presentations in this session

Presentation thumbnail
Welcome and introduction
Professor M. Cikes (Zagreb, HR)
Slides Video
Presentation thumbnail
Improving outcomes for the heart and kidney: the role of mineralocorticoid receptor antagonists (MRAs)
Professor B. Bozkurt (Houston, US)
Slides Video
Presentation thumbnail
MRAs in heart failure with reduced rejection fraction (HFrEF): a cornerstone of guideline-recommended medical therapy
Professor M. Cikes (Zagreb, HR)
Slides Video
Presentation thumbnail
Non-steroidal mineralocorticoid receptor antagonists (nsMRAs) in heart failure with mid-range and preserved ejection fraction: establishing a new standard in heart failure care
Professor J. Butler (Dallas, US)
Slides Video
Presentation thumbnail
nsMRAs: what emerging trials tell us about the future of heart failure therapy
Professor J. McMurray (Glasgow, GB)
Slides Video

Access the full session

Session thumbnail
Redefining mineralocorticoid receptor antagonism in cardio-kidney-metabolic syndrome: from evidence to innovation
Video

The Event

Event poster

Heart Failure 2025

18 May 2025 15:36 CET
You may be interested in
thumbnail
Congress Session
Protecting the heart and kidneys: the role of finerenone
12 May 2024
thumbnail
Congress Session
Ask the Trialists - DAPA ACT HF-TIMI 68
30 August 2025
thumbnail
Congress Presentation
Controversies in contemporary drug therapy for heart failure - discussion
9 May 2026
thumbnail
Congress Presentation
Discussion.
29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources